Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients with advanced diabetic kidney disease, kidney transplantation (KT) with or without a pancreas transplant is the treatment of choice. We aimed to review current data regarding kidney and pancreas transplant options in patients with both type 1 and 2 diabetes and the outcomes of different treatment modalities. In general, pancreas transplantation is associated with long-term survival advantages despite an increased short-term morbidity and mortality risk. This applies to simultaneous pancreas kidney transplantation or pancreas after KT compared to KT alone (either living donor or deceased). Other factors as living donor availability, comorbiditi...
Background: The performance of simultaneous pancreas/kidney (SPK) transplantation is an acceptable t...
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved m...
OBJECTIVE In patients with type 1 diabetes and end-stage renal disease, it is controversial whether ...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Type 1 as well as Type 2 diabetic patients in end-stage renal failure and with no contraindications ...
Background and objectives: Transplant options for type I diabetics with end-stage renal disease incl...
For patients with type 1 diabetes complicated by end stage renal disease (ESRD), kidney transplantat...
Pancreas transplantation is now standard of care for selected patients with diabetes and end-stage r...
Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. The dec...
Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3millionAmericans. It...
Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients wi...
In patients with end-stage chronic kidney disease (CKD) and type 1 diabetes mellitus (DM 1), simult...
In the United States, diabetes mellitus is the third most commondisease and fourth leading cause of ...
Pancreas transplantation is considered a therapeutic option for patients with complicated diabetes m...
Background: The performance of simultaneous pancreas/kidney (SPK) transplantation is an acceptable t...
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved m...
OBJECTIVE In patients with type 1 diabetes and end-stage renal disease, it is controversial whether ...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients w...
Type 1 as well as Type 2 diabetic patients in end-stage renal failure and with no contraindications ...
Background and objectives: Transplant options for type I diabetics with end-stage renal disease incl...
For patients with type 1 diabetes complicated by end stage renal disease (ESRD), kidney transplantat...
Pancreas transplantation is now standard of care for selected patients with diabetes and end-stage r...
Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. The dec...
Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3millionAmericans. It...
Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients wi...
In patients with end-stage chronic kidney disease (CKD) and type 1 diabetes mellitus (DM 1), simult...
In the United States, diabetes mellitus is the third most commondisease and fourth leading cause of ...
Pancreas transplantation is considered a therapeutic option for patients with complicated diabetes m...
Background: The performance of simultaneous pancreas/kidney (SPK) transplantation is an acceptable t...
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved m...
OBJECTIVE In patients with type 1 diabetes and end-stage renal disease, it is controversial whether ...